Key facts
- Notable investors include Lumina Growth Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Denver Life Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Denver Life Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Denver Life Sciences
Operator of a consumer health monitoring system designed for tracking physiological biomarkers. The company's system incorporates advanced engineering and design to deliver real-time data on hydration levels and other key health indicators, enabling health-conscious individuals and professionals to make informed decisions through precise measurements, continuous monitoring, and integration with personalized wellness routines.
- Sector
- Healthcare
- HQ
- Highlands Ranch, CO, United States
- Founded
- 2023
- Employees
- 7
- Website
- dls.co/
- Ownership
- Privately Held (backing)
Denver Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Denver Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Denver Life Sciences in its N-PORT filings yet. We sweep new filings monthly.